Package 55513-399-01

{"route": ["SUBCUTANEOUS"], "spl_id": "f3cd4d42-a699-4a6e-b954-dcca06b272c3", "openfda": {"nui": ["N0000175610", "N0000175451", "M0001357"], "upc": ["6377113400015"], "unii": ["FYS6T7F842"], "rxcui": ["2627711", "2627717", "2627719", "2627722", "2627724", "2627725", "2634478", "2634479", "2663901", "2663904", "2663906", "2663907", "2663908", "2663910", "2663912", "2663913", "2663914", "2663915"], "spl_set_id": ["9c44bd5b-4464-40a4-8933-8680950f00f2"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Amgen, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (55513-399-01)  / .2 mL in 1 SYRINGE", "package_ndc": "55513-399-01", "marketing_start_date": "20230814"}], "brand_name": "AMJEVITA", "product_id": "55513-399_f3cd4d42-a699-4a6e-b954-dcca06b272c3", "dosage_form": "INJECTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "55513-399", "generic_name": "adalimumab-atto", "labeler_name": "Amgen, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AMJEVITA", "active_ingredients": [{"name": "ADALIMUMAB", "strength": "20 mg/.2mL"}], "application_number": "BLA761024", "marketing_category": "BLA", "marketing_start_date": "20230814", "listing_expiration_date": "20261231"}